Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

225
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
225
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

188
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
188
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

299
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
299
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

309
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
309
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

172
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
172
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

414
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
414

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Knowledge, enablers, and barriers to TB preventive treatment among health care workers.

Public health action·2025
Same author

Impact of social franchising on TB contact investigation and uptake of TB preventive therapy.

Public health action·2025
Same author

Overview of Australia's state-wide cardiovascular program and reflections on its piloting between 2021 and 2024.

Health policy (Amsterdam, Netherlands)·2025
Same author

Pediatric Perioperative Mortality in Southeastern (SE) Nigeria-A Multicenter, Prospective Study.

Nigerian journal of clinical practice·2025
Same author

Effect of a needs-based model of care on the characteristics of healthcare services in England: the i-THRIVE National Implementation Programme.

Epidemiology and psychiatric sciences·2025
Same author

Comparative analysis of the impact of portable digital X-ray on TB screening in hard-to-reach areas in Nigeria.

Public health action·2025
Same journal

Compliance with intermittent preventive malaria treatment in pregnancy at a tertiary hospital in Sierra Leone.

Public health action·2026
Same journal

From fellows to leaders: lessons learned from the WHO/TDR Clinical Research and Development Fellowship (1999-2021).

Public health action·2026
Same journal

Comprehensive assessment of adults severely ill with TB referred after triage in Tamil Nadu, India.

Public health action·2026
Same journal

Tuberculosis preventive therapy in Sierra Leone: early implementation gaps and lessons learned.

Public health action·2026
Same journal

Effectiveness and challenges of DOT in multidrug-resistant TB: a 12-year retrospective study.

Public health action·2026
Same journal

Unmasking the appeal - tobacco and vaping companies have recruited a new generation of nicotine dependents.

Public health action·2026
See all related articles

Related Experiment Video

Updated: Aug 27, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.2K

Improving TB case notification and treatment coverage through data use.

O O Chijioke-Akaniro1, E Ubochioma1, A Omoniyi2

  • 1National Tuberculosis, Leprosy and Buruli Ulcer Control Programme, Abuja, Nigeria.

Public Health Action
|September 26, 2022
PubMed
Summary
This summary is machine-generated.

Improved data use in Nigeria significantly boosted tuberculosis (TB) case notification and treatment coverage. Strategic interventions led to increased TB case finding and expanded DOTS facility coverage.

Keywords:
programmesecondary datatuberculosis services

More Related Videos

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.2K
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

80.9K

Related Experiment Videos

Last Updated: Aug 27, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.2K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.2K
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

80.9K

Area of Science:

  • Public Health
  • Epidemiology
  • Health Services Research

Background:

  • National tuberculosis (TB) data analysis was conducted in Nigeria.
  • Previous TB control efforts may have been limited by data utilization.
  • Understanding trends in TB case notification and treatment is crucial for public health interventions.

Purpose of the Study:

  • To evaluate the impact of enhanced data utilization on TB case notification and treatment coverage in Nigeria.
  • To assess the effectiveness of interventions aimed at improving TB data management and actionability.
  • To determine if improved data use leads to better TB program outcomes.

Main Methods:

  • Analysis of pre- and post-intervention secondary TB program data.
  • Inclusion of data on increased supervisory visits, health worker incentives, DOTS expansion, outreaches, and geo-code monitoring.
  • Application of Cochran-Armitage chi-squared test for linear trend analysis.

Main Results:

  • Tuberculosis case-finding increased from 104,904 in 2017 to 138,591 in 2020, with significant annual percentage increases (P < 0.001).
  • Facility DOTS coverage rose substantially from 7,389 in 2017 to 17,699 in 2020, showing significant year-on-year growth (P < 0.001).
  • Treatment coverage rate improved from 24% in 2018 to 30% in 2020.

Conclusions:

  • Expansion of TB services, coupled with enhanced monitoring, is vital for improving TB treatment coverage.
  • Effective data utilization for decision-making is a key driver in increasing TB treatment success rates.
  • The study highlights the importance of data-informed strategies in strengthening national TB control programs.